Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
10/19/2000 | WO2000024634A9 Systems and methods for modifying ice adhesion strength |
10/19/2000 | WO2000024405A9 Compounds and their therapeutic use with diabetic complications |
10/19/2000 | WO2000023625A3 Isolated nucleic acid molecules which encode scp proteins, and uses thereof |
10/19/2000 | WO2000019883A9 Compositions and methods of disease diagnosis and therapy |
10/19/2000 | WO2000016092A3 Energetic quantification method for composite materials |
10/19/2000 | WO2000013702A9 Use of an angiogenic factor for the treatment of microvascular angiopathies |
10/19/2000 | WO2000009070A3 Inhibition of pathogenic processes related to tissue trauma |
10/19/2000 | DE19919285C1 Feeding and/or watering device for domestic animals has sensor for detecting respiration parameter used for identifying animal for corresponding control of feeding and/or watering device |
10/19/2000 | DE19917052A1 Chemical or biochemical assay, involving electrochemically assessing a change in diffusion coefficient of redox-active species due to a specific binding reaction, useful e.g. for determining antigens or DNA fragments |
10/19/2000 | DE19916929A1 New oligonucleotide primers, useful for amplifying human telomerase RNA for diagnosis, prognosis and monitoring of cancer |
10/19/2000 | DE19916242A1 PSA-haltige Substanz und deren Verwendung PSA-containing substance and its use |
10/19/2000 | DE19915057A1 Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung Monoclonal antibodies to human protein Mcm3, processes for their preparation and their use |
10/19/2000 | DE19913076A1 Vorrichtung und Verfahren zum Aufbringen von Mikrotröpfchen auf ein Substrat Apparatus and method for applying microdroplets onto a substrate |
10/19/2000 | DE19911867A1 Detection of gases or vapors in air involves using a sensor element having a gas sensitive layer and heated by using an electric heater |
10/19/2000 | DE10016545A1 Quantitative determination of organophosphorus compounds by replacing the cations in solution with hydrogen ions, concentrating the solution, decomposing the compounds to orthophosphate and measuring orthophosphate content |
10/19/2000 | DE10013278A1 Verfahren zur Konzentrationsbestimmung einer Zielsubstanz unter Verwendung eines Quarzoszillators und eine Vorrichtung hierfür A method for determining the concentration of a target substance using a quartz oscillator and an apparatus therefor |
10/19/2000 | CA2704600A1 A method for producing antibodies with increased adcc activity |
10/19/2000 | CA2652131A1 Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker |
10/19/2000 | CA2382628A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
10/19/2000 | CA2372171A1 Benzodiazepine derivatives for imaging thrombi |
10/19/2000 | CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
10/19/2000 | CA2371223A1 49 human secreted proteins |
10/19/2000 | CA2371172A1 50 human secreted proteins |
10/19/2000 | CA2370767A1 49 human secreted proteins |
10/19/2000 | CA2370563A1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
10/19/2000 | CA2370562A1 49 human secreted proteins |
10/19/2000 | CA2370523A1 49 human secreted proteins |
10/19/2000 | CA2370489A1 49 human secreted proteins |
10/19/2000 | CA2370237A1 Methods for the diagnosis and treatment of metastatic prostate tumors |
10/19/2000 | CA2370189A1 48 human secreted proteins |
10/19/2000 | CA2370131A1 62 human secreted proteins |
10/19/2000 | CA2370116A1 Methods of forming monolayers and uses thereof |
10/19/2000 | CA2370112A1 Uncoupling proteins |
10/19/2000 | CA2370018A1 Complex formed by n-linked glycoproteins (siblings) and factor h |
10/19/2000 | CA2370000A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin |
10/19/2000 | CA2369892A1 Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same |
10/19/2000 | CA2369883A1 Method for judging autoimmune disease, method for detecting anti-reg protein autoantibody and diagnostics for autoimmune diseases |
10/19/2000 | CA2369629A1 Method to type prion proteins |
10/19/2000 | CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer |
10/19/2000 | CA2369484A1 Assessment of gastric emptying disorders |
10/19/2000 | CA2369420A1 Treatment of myeloma bone disease with proteasomal and nf-kb activity inhibitors |
10/19/2000 | CA2369413A1 Transmembrane protein expressed in prostate and other cancers |
10/19/2000 | CA2369273A1 Assessment of psychiatric and neurological conditions |
10/19/2000 | CA2369156A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
10/19/2000 | CA2369016A1 Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology |
10/19/2000 | CA2369004A1 Method and device for controlling a vat containing oil or cooking fat in situ |
10/19/2000 | CA2368903A1 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
10/19/2000 | CA2368875A1 High sensitivity phage display biomolecule detection |
10/19/2000 | CA2367541A1 Encoding scheme for solid phase chemical libraries |
10/19/2000 | CA2366643A1 Method for mapping a dna molecule comprising an ad infinitum amplification step |
10/19/2000 | CA2366520A1 Anti-bacterial vaccine compositions |
10/19/2000 | CA2366359A1 Novel essential bacterial genes and their proteins |
10/19/2000 | CA2365996A1 Electronically mediated nucleic acid amplification in nasba |
10/19/2000 | CA2365945A1 Products and methods for treating ptp lar related diseases |
10/19/2000 | CA2365929A1 Novel method for identifying antibacterial compounds |
10/19/2000 | CA2365919A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents |
10/19/2000 | CA2365918A1 49 human secreted proteins |
10/19/2000 | CA2365917A1 Bone morphogenic proteins |
10/19/2000 | CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
10/19/2000 | CA2365910A1 Human proteins and polynucleotides encoding them |
10/19/2000 | CA2365908A1 Reagents and methods for identifying and modulating expression of genes regulated by p21 |
10/19/2000 | CA2365905A1 48 human secreted proteins |
10/19/2000 | CA2365623A1 Tyrosine kinase substrate (tks) proteins |
10/19/2000 | CA2365522A1 48 human secreted proteins |
10/19/2000 | CA2364690A1 Novel transduction molecules and methods for using same |
10/19/2000 | CA2364541A1 Genes associated with diseases of the kidney |
10/19/2000 | CA2360318A1 A second mammalian tankyrase |
10/18/2000 | EP1045250A1 A global test for evaluating the functionality of the thrombin/antithrombin system |
10/18/2000 | EP1045249A1 Apparatus for applying cells on a plate for analysis |
10/18/2000 | EP1045248A2 Luminescent labeled immunoassay method and analysis element therefor |
10/18/2000 | EP1045247A2 A method for separating and assaying lipoprotein, an assembly for performing such a method, and a system including such an assembly |
10/18/2000 | EP1045246A1 Evaluation and regulation of the thermal power of a stream of combustible gas, and characterization of thermal mass flowmeter |
10/18/2000 | EP1045245A2 Method and device for monitoring ammoniacalised steam cycles |
10/18/2000 | EP1045243A2 Method of analyzing concentration of target substance using quartz oscillator and device therefor |
10/18/2000 | EP1045239A1 Method of preparing slag sample for x-ray fluorescence analysis and sampler |
10/18/2000 | EP1045036A2 Methods and devices for performing analysis of a nucleic acid sample |
10/18/2000 | EP1045035A2 Cell for measuring the ability to control the activity of a ligand-responsive transcription control factor |
10/18/2000 | EP1045034A2 Amplification and detection of shiga-like toxin II producing organisms |
10/18/2000 | EP1045033A2 Amplification and detection of shiga-like toxin I producing organisms |
10/18/2000 | EP1045032A2 Amplification and detection of salmonella spp |
10/18/2000 | EP1045031A2 Amplification and detection of Yersinia enterocolitica |
10/18/2000 | EP1044986A2 Amplification and detection of shigella spp. and enteroinvasive strains of escherichia coli |
10/18/2000 | EP1044651A1 Control apparatus for an automated surgical biopsy device |
10/18/2000 | EP1044605A1 Gene mutant animals |
10/18/2000 | EP1044377A1 Process for detecting borna disease virus (bdv) infections |
10/18/2000 | EP1044376A1 Analytical method using particles and test kit for performing the method |
10/18/2000 | EP1044375A1 Method comprising capture molecule fixed on disc surface |
10/18/2000 | EP1044374A1 Biosensor |
10/18/2000 | EP1044373A1 Method using a new calibrator and a device and test kit including the calibrator |
10/18/2000 | EP1044372A1 Analytical method comprising addition in two or more positions and a device and test kit therefor |
10/18/2000 | EP1044371A1 Method and apparatus for on-line testing samples |
10/18/2000 | EP1044364A1 Method and reagents for the quantification of solid-phase reactions using fluorine nmr |
10/18/2000 | EP1044360A1 Test device, method and system for detection of an analyte |
10/18/2000 | EP1044359A1 Method and device for measuring concentration |
10/18/2000 | EP1044357A1 Method and device for the quasi-continuous analysis of inorganic or organic substances contained in fluids |
10/18/2000 | EP1044283A1 Fluorometric method for monitoring and detecting nucleic acid amplification |
10/18/2000 | EP1044280A1 SELECTIVE KILLING AND DIAGNOSIS OF p53?+ NEOPLASTIC CELLS |
10/18/2000 | EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE |
10/18/2000 | EP1044269A1 Human vps35/mem3-related protein |
10/18/2000 | EP1044267A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |